{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T22:32:11Z","timestamp":1791844331123,"version":"4.3.4"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009553","name":"Agentura Pro Zdravotnick\u00fd V\u00fdzkum \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministry of Health of the Czech Republic","doi-asserted-by":"publisher","award":["NU22-10-00054"],"award-info":[{"award-number":["NU22-10-00054"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Bone Oncology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jbo.2026.100766","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T23:39:01Z","timestamp":1777073941000},"page":"100766","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Dual-target neoadjuvant therapy with denosumab and sunitinib for giant cell tumor of bone: a sarcoma center experience"],"prefix":"10.1016","volume":"58","author":[{"given":"Michal","family":"Mahdal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9719-4769","authenticated-orcid":false,"given":"Vasileios","family":"Apostolopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"M\u00fadr\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Neradil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"Kub\u00ed\u010dek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Du\u0161an","family":"Zoufal\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar","family":"Ad\u00e1mkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5501-2143","authenticated-orcid":false,"given":"Tom\u00e1\u0161","family":"Tom\u00e1\u0161","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2021","key":"10.1016\/j.jbo.2026.100766_b0005","first-page":"119","article-title":"The WHO Classification of Tumors of Bone: An Updated Review","volume":"28","author":"Choi","year":"2020","journal-title":"Advances in Anatomic Pathology"},{"key":"10.1016\/j.jbo.2026.100766_b0010","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12885-020-07739-8","article-title":"Malignancy in giant cell tumor of bone: analysis of an open-label phase 2 study of denosumab","volume":"21","author":"Palmerini","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jbo.2026.100766_b0015","unstructured":"Unni KK, Inwards CY, Unni KK, Inwards CY. Dahlin\u2019s Bone Tumors: General Aspects And Data on 10,165 Cases. 6th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2010., n.d."},{"key":"10.1016\/j.jbo.2026.100766_b0020","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4081\/rt.2009.e52","article-title":"The epidemiology of malignant giant cell tumors of bone: an analysis of data from the Surveillance, Epidemiology and End Results Program (1975\u20132004)","volume":"1","author":"Beebe-Dimmer","year":"2009","journal-title":"Rare Tumors"},{"key":"10.1016\/j.jbo.2026.100766_b0025","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1051\/sicotj\/2017041","article-title":"Giant cell tumor of bone revisited","volume":"3","author":"Mavrogenis","year":"2017","journal-title":"SICOT-J"},{"key":"10.1016\/j.jbo.2026.100766_b0030","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2106\/00004623-198769010-00018","article-title":"Giant-cell tumor of bone","volume":"69","author":"Campanacci","year":"1987","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.jbo.2026.100766_b0035","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00432-008-0370-x","article-title":"Giant cell tumor of bone: treatment and outcome of 214 cases","volume":"134","author":"Balke","year":"2008","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.jbo.2026.100766_b0040","doi-asserted-by":"crossref","first-page":"52","DOI":"10.55095\/achot2024\/068","article-title":"Combined Proximal Radius Reconstruction Following Resection for Oncological Indication","volume":"92","author":"Malina","year":"2025","journal-title":"ACHOT"},{"key":"10.1016\/j.jbo.2026.100766_b0045","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1007\/s11999-010-1448-8","article-title":"Recurrence after and complications associated with adjuvant treatments for sacral giant cell tumor","volume":"468","author":"Ruggieri","year":"2010","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.jbo.2026.100766_b0050","doi-asserted-by":"crossref","first-page":"4664","DOI":"10.3390\/cancers15184664","article-title":"Proximal Tibia Tumour Location and Curettage Are Major Risk Factors of Local Recurrence in Giant Cell Tumour of Bone","volume":"15","author":"Mahdal","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.jbo.2026.100766_b0055","doi-asserted-by":"crossref","first-page":"36332","DOI":"10.1038\/srep36332","article-title":"Recurrence Rates and Risk Factors for Primary Giant Cell Tumors around the Knee: A Multicentre Retrospective Study in China","volume":"6","author":"Hu","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jbo.2026.100766_b0060","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.jcot.2019.09.017","article-title":"Present day controversies and consensus in curettage for giant cell tumor of bone","volume":"10","author":"Errani","year":"2019","journal-title":"J Clin Orthop Trauma"},{"key":"10.1016\/j.jbo.2026.100766_b0065","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.1245\/s10434-022-11411-9","article-title":"Preoperative Denosumab Therapy Against Giant Cell Tumor of Bone is Associated with an Increased Risk of Local Recurrence After Curettage Surgery","volume":"29","author":"Asano","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jbo.2026.100766_b0070","doi-asserted-by":"crossref","DOI":"10.1177\/2309499020929786","article-title":"Preoperative denosumab treatment with curettage may be a risk factor for recurrence of giant cell tumor of bone","volume":"28","author":"Sano","year":"2020","journal-title":"J Orthop Surg (Hong Kong)"},{"key":"10.1016\/j.jbo.2026.100766_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2018.06.017","article-title":"Giant cell tumor of bone: updated molecular pathogenesis and tumor biology","volume":"81","author":"Noh","year":"2018","journal-title":"Human Pathology"},{"key":"10.1016\/j.jbo.2026.100766_b0080","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S1470-2045(13)70277-8","article-title":"Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study","volume":"14","author":"Chawla","year":"2013","journal-title":"The Lancet Oncology"},{"key":"10.1016\/j.jbo.2026.100766_b0085","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1177\/1602400221","article-title":"Wide Resection versus Curettage with Adjuvant Therapy for Giant Cell Tumour of Bone","volume":"24","author":"Kamal","year":"2016","journal-title":"J Orthop Surg (Hong Kong)"},{"key":"10.1016\/j.jbo.2026.100766_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ctrv.2009.09.002","article-title":"Giant cell tumor of the extremity: A review of 349 cases from a single institution","volume":"36","author":"Errani","year":"2010","journal-title":"Cancer Treatment Reviews"},{"key":"10.1016\/j.jbo.2026.100766_b0095","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/01.blo.0000160024.06739.ff","article-title":"Does Curettage without Adjuvant Therapy Provide Low Recurrence Rates in Giant-Cell Tumors of Bone?","author":"Prosser","year":"2005","journal-title":"Clinical Orthopaedics and Related Research NA"},{"key":"10.1016\/j.jbo.2026.100766_b0100","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.3390\/cancers13153647","article-title":"Current Concepts in the Treatment of Giant Cell Tumors of Bone","volume":"13","author":"Tsukamoto","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.jbo.2026.100766_b0105","first-page":"20","article-title":"Intralesional curettage and surgical adjuvants in the treatment of giant cell tumor of bone: meta-analysis and systematic review, Chin","volume":"13","author":"Leng","year":"2024","journal-title":"Clin Oncol"},{"key":"10.1016\/j.jbo.2026.100766_b0110","article-title":"Micro-CT, Mechanical, and Histological Examination of the Effect of Local Adjuvants on Porcine Cortical Bone Following Intralesional Curettage of Bone Tumors","author":"Apostolopoulos","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jbo.2026.100766_b0115","doi-asserted-by":"crossref","first-page":"98","DOI":"10.5704\/MOJ.2303.012","article-title":"The Efficacy of Bisphosphonate in the Treatment of Giant Cell Tumour of the Bone","volume":"17","author":"Mf","year":"2023","journal-title":"A Systematic Review and Meta-Analysis, Malays Orthop J"},{"key":"10.1016\/j.jbo.2026.100766_b0120","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/CCO.0000000000000645","article-title":"Current concepts in the treatment of giant cell tumour of bone","volume":"32","author":"van der Heijden","year":"2020","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.jbo.2026.100766_b0125","article-title":"Denosumab in Giant Cell Tumor of Bone: Current Status and Pitfalls","volume":"10","author":"Li","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jbo.2026.100766_b0130","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.ejso.2018.03.020","article-title":"Denosumab treatment of inoperable or locally advanced giant cell tumor of bone \u2013 Multicenter analysis outside clinical trial","volume":"44","author":"Rutkowski","year":"2018","journal-title":"European Journal of Surgical Oncology"},{"key":"10.1016\/j.jbo.2026.100766_b0135","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11864-020-00766-4","article-title":"Role of (Neo)adjuvant Denosumab for Giant Cell Tumor of Bone","volume":"21","author":"Palmerini","year":"2020","journal-title":"Curr. Treat. Options in Oncol."},{"key":"10.1016\/j.jbo.2026.100766_b0140","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.3390\/cancers13143543","article-title":"New Target for Precision Medicine Treatment of Giant-Cell Tumor of Bone: Sunitinib Is Effective in the Treatment of Neoplastic Stromal Cells with Activated PDGFR\u03b2 Signaling","volume":"13","author":"Mahdal","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.jbo.2026.100766_b0145","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.phrs.2018.01.021","article-title":"The role of small molecule platelet-derived growth factor receptor (PDGFR) inhibitors in the treatment of neoplastic disorders","volume":"129","author":"Roskoski","year":"2018","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jbo.2026.100766_b0150","doi-asserted-by":"crossref","first-page":"6282","DOI":"10.1245\/s10434-024-15397-4","article-title":"Micro-CT, Mechanical, and Histological Examination of the Effect of Local Adjuvants on Porcine Cortical Bone Following Intralesional Curettage of Bone Tumors","volume":"31","author":"Apostolopoulos","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jbo.2026.100766_b0155","doi-asserted-by":"crossref","first-page":"930","DOI":"10.3389\/fonc.2019.00930","article-title":"Phospho-Protein Arrays as Effective Tools for Screening Possible Targets for Kinase Inhibitors and Their Use in Precision Pediatric Oncology","volume":"9","author":"Neradil","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jbo.2026.100766_b0160","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat Methods"},{"key":"10.1016\/j.jbo.2026.100766_b0165","first-page":"1626","article-title":"Prognostic factors for local recurrence in extremity-located giant cell tumours of bone with pathological fracture","author":"Medellin","year":"2018","journal-title":"The Bone & Joint Journal 100-B"},{"key":"10.1016\/j.jbo.2026.100766_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2025.117566","article-title":"Biomarkers and therapeutic targets in giant cell tumor of bone: A comprehensive review","volume":"199","author":"Knechtova","year":"2025","journal-title":"Bone"}],"container-title":["Journal of Bone Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221213742600028X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221213742600028X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T23:24:20Z","timestamp":1783121060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221213742600028X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":34,"alternative-id":["S221213742600028X"],"URL":"https:\/\/doi.org\/10.1016\/j.jbo.2026.100766","relation":{},"ISSN":["2212-1374"],"issn-type":[{"value":"2212-1374","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual-target neoadjuvant therapy with denosumab and sunitinib for giant cell tumor of bone: a sarcoma center experience","name":"articletitle","label":"Article Title"},{"value":"Journal of Bone Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbo.2026.100766","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"100766"}}